Exagen Inc reports results for the quarter ended in June - Earnings Summary

Exagen

09/08/2021 22:39

* Exagen Inc  XGN.OQ  reported a quarterly adjusted loss of 38
cents​​ per share for the quarter ended in June. The mean
expectation of six analysts for the quarter was for a loss of 44
cents per share.
* Revenue rose 42.7% to $12.77 million from a year ago; 
analysts expected $11.48 million. 
* Exagen Inc's reported EPS for the quarter was a loss of 38
cents​.
* The mean earnings estimate of analysts had fallen by
about 6.1% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Exagen Inc shares had fallen by 30.3% this quarter and
lost 20.8% so far this year.
* The company reported a quarterly loss of $6.41 million.
* Wall Street's median 12-month price target for Exagen Inc is
$25.00 
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 6 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
This summary was machine generated August 9 at 09:38 p.m.  ​All
figures in US dollars unless otherwise stated